mefloquine has been researched along with Behavior Disorders in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 15 (46.88) | 18.2507 |
2000's | 14 (43.75) | 29.6817 |
2010's | 3 (9.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Block, J; Nevin, RL; Ritchie, EC | 1 |
Grabias, B; Kumar, S | 1 |
Chelo, D; Djoukoue, F; Frey, SG; Hatz, C; Kinkela, MN; Tietche, F; Weber, P | 1 |
Odenholt, I; Petersson, H; Rietz, G | 1 |
Baran, B; Gazdag, G; Murai, Z; Szily, E; Tolna, J | 1 |
Pepplinkhuizen, L; Stricker, BH; Sturkenboom, MC; van Riemsdijk, MM | 1 |
Strauss, BA; Tepper, ML | 1 |
Corbeil, TE; Goldfinger, WE; Hansen, CJ; Reed, RJ; Ryan, MA; Smith, B; Smith, TC; Spooner, CN; Wang, LZ; Wells, TS | 1 |
Alisky, JM; Chertkova, EL; Iczkowski, KA | 1 |
Aarnoudse, AL; Dieleman, J; Ligthelm, RJ; Molokhia, M; Overbosch, D; Stricker, BH; van der Heiden, IP; van Riemsdijk, MM; van Schaik, RH | 1 |
Croft, AM | 1 |
Black, J | 1 |
Lench, P | 1 |
Bazin, N; Bisaro, F; Bourée, P; Feline, A; Hennequin, C | 1 |
Bernardo, M; Parellada, E | 1 |
Barrett, PJ; Bradley, DJ; Clarke, PD; Emmins, PD | 1 |
Behrens, RH; Corbett, EL; Doherty, JP | 1 |
Phillips, M | 1 |
Dollow, S | 1 |
Warner, J | 1 |
Ellis-Pegler, RB; Ingram, RJ | 1 |
Bygbjerg, IC; Gøtzsche, PC; Rønn, AM; Rønne-Rasmussen, J | 1 |
Jensen, JJ | 1 |
Bygbjerg, IC; Rønn, AM | 1 |
Beny, A; Potasman, I; Seligmann, H | 1 |
Abell, L | 1 |
Javorsky, DJ; Keitner, GI; Parmentier, AH; Tremont, G | 1 |
Eichenlaub, D; Fleischer, K; Held, T; Kern, W; Pohle, HD; Trautmann, M; Weber, G; Weinke, T | 1 |
Held, T; Mravak, S; Trautmann, M; Weinke, T | 1 |
2 review(s) available for mefloquine and Behavior Disorders
Article | Year |
---|---|
Adverse neuropsychiatric effects of antimalarial drugs.
Topics: Antimalarials; Humans; Malaria; Mefloquine; Mental Disorders; Neurotoxicity Syndromes | 2016 |
A lesson learnt: the rise and fall of Lariam and Halfan.
Topics: Antimalarials; Drug Industry; Financing, Government; Forecasting; Humans; Interprofessional Relations; Malaria; Mefloquine; Mental Disorders; Military Personnel; Phenanthrenes; Technology, Pharmaceutical; United States; United States Food and Drug Administration | 2007 |
2 trial(s) available for mefloquine and Behavior Disorders
Article | Year |
---|---|
Artesunate-mefloquine combination therapy in acute Plasmodium falciparum malaria in young children: a field study regarding neurological and neuropsychiatric safety.
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Mental Disorders; Nervous System Diseases; Plasmodium falciparum | 2010 |
[Clinical experiences with mefloquine in tropical malaria--a prospective study].
Topics: Adolescent; Adult; Africa, Western; Animals; Female; Germany; Humans; Madagascar; Malaria; Male; Mefloquine; Mental Disorders; Nausea; Nervous System Diseases; Plasmodium falciparum; Prospective Studies; Travel; Uganda; Vomiting | 1991 |
28 other study(ies) available for mefloquine and Behavior Disorders
Article | Year |
---|---|
Psychiatric side effects of mefloquine: applications to forensic psychiatry.
Topics: Adverse Drug Reaction Reporting Systems; Aggression; Antimalarials; Comorbidity; Contraindications; Diagnosis, Differential; Drug Labeling; Expert Testimony; Humans; Insanity Defense; Liability, Legal; Mefloquine; Mental Disorders; Neuropsychological Tests; Psychoses, Substance-Induced; Suicide; Violence | 2013 |
[Many travellers suffer of side-effects of malaria prophylaxis].
Topics: Antimalarials; Chloroquine; Drug Eruptions; Gastrointestinal Diseases; Humans; Malaria; Mefloquine; Mental Disorders; Proguanil; Surveys and Questionnaires; Travel | 2002 |
FDA requires warnings on anti-malaria drug Lariam.
Topics: Antimalarials; Consumer Product Safety; Drug Labeling; Humans; Mefloquine; Mental Disorders; United States; United States Food and Drug Administration | 2004 |
[Neuropsychiatric symptoms caused by mefloquine (report of several cases)].
Topics: Adult; Antimalarials; Depression; Female; Humans; Malaria; Male; Mefloquine; Mental Disorders; Middle Aged; Panic Disorder; Primary Prevention; Psychoses, Substance-Induced; Retrospective Studies; Travel | 2005 |
Mefloquine increases the risk of serious psychiatric events during travel abroad: a nationwide case-control study in the Netherlands.
Topics: Adult; Affective Disorders, Psychotic; Antimalarials; Case-Control Studies; Cohort Studies; Female; Humans; Insurance; Insurance, Health, Reimbursement; International Agencies; International Cooperation; Malaria; Male; Mefloquine; Mental Disorders; Middle Aged; Netherlands; Odds Ratio; Risk Factors; Sex Factors; Surveys and Questionnaires; Travel | 2005 |
Methodological concerns regarding the relation between mefloquine and serious psychiatric events in females.
Topics: Antimalarials; Case-Control Studies; Female; Humans; Malaria; Male; Mefloquine; Mental Disorders; Mental Recall; Research Design; Sex Characteristics; Sex Distribution; Sex Factors; Travel | 2006 |
Mefloquine use and hospitalizations among US service members, 2002-2004.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antimalarials; Cohort Studies; Europe; Female; Hospitalization; Hospitals, Military; Humans; Japan; Malaria; Male; Mefloquine; Mental Disorders; Military Personnel; Proportional Hazards Models; Severity of Illness Index; Travel; United States | 2006 |
Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis.
Topics: Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chloroquine; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Humans; Loperamide; Mefloquine; Mental Disorders; Psychotic Disorders | 2006 |
MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine.
Topics: Adult; Aged; Antimalarials; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Confidence Intervals; Cysteine; Female; Gene Frequency; Genes, MDR; Glycine; Haplotypes; Humans; Male; Mefloquine; Mental Disorders; Middle Aged; Nervous System Diseases; Odds Ratio; Organic Anion Transporters; Polymorphism, Genetic; Reference Values; Threonine; Travel; White People | 2006 |
Lariam and Halfan.
Topics: Antimalarials; Humans; Malaria; Mefloquine; Mental Disorders; Phenanthrenes; Randomized Controlled Trials as Topic; Time Factors | 2007 |
Malaria prophylaxis. Psychological problems after mefloquine and chloroquine.
Topics: Chloroquine; Humans; Malaria; Mefloquine; Mental Disorders | 1995 |
Severe psychiatric side effects observed during prophylaxis and treatment with mefloquine.
Topics: Adult; Humans; Male; Mefloquine; Mental Disorders; Middle Aged | 1994 |
[Mefloquine and severe psychiatric disorder].
Topics: Humans; Mefloquine; Mental Disorders | 1994 |
Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers.
Topics: Adult; Antimalarials; Chloroquine; Drug Therapy, Combination; Female; Health Surveys; Hospitalization; Humans; Malaria; Male; Mefloquine; Mental Disorders; Nervous System Diseases; Proguanil; Retrospective Studies; Travel; Treatment Refusal; United Kingdom | 1996 |
Adverse events associated with mefloquine. Study in returned travellers confirms authors' findings.
Topics: Adult; Antimalarials; Chloroquine; Drug Combinations; Humans; Mefloquine; Mental Disorders; Proguanil; Travel | 1996 |
Adverse events associated with mefloquine. Women may be more susceptible to adverse events.
Topics: Antimalarials; Doxycycline; Drug Combinations; Female; Humans; Male; Mefloquine; Mental Disorders; Sex Characteristics | 1996 |
Adverse events associated with mefloquine. Risk-benefit ratio must be taken into account.
Topics: Antimalarials; Chloroquine; Drug Combinations; Humans; Mefloquine; Mental Disorders; Proguanil; Risk Factors; Travel | 1996 |
Adverse events associated with mefloquine. Advice to warn patients about rare side effects overturns accepted practice.
Topics: Antimalarials; Duty to Warn; Humans; Mefloquine; Mental Disorders | 1996 |
Malaria, mefloquine and the mind.
Topics: Antimalarials; Central Nervous System Diseases; Female; Humans; Malaria; Male; Mefloquine; Mental Disorders; Travel | 1997 |
Neuropsychiatric manifestations after mefloquine therapy for Plasmodium falciparum malaria: comparing a retrospective and a prospective study.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antimalarials; Bias; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Mental Disorders; Nervous System Diseases; Prevalence; Prospective Studies; Research Design; Retrospective Studies; Surveys and Questionnaires | 1998 |
[Mefloquine: neuropsychiatric adverse effects are often severe and persistent long after withdrawal of the drug].
Topics: Adult; Antimalarials; Anxiety Disorders; Female; Humans; Male; Mefloquine; Mental Disorders; Middle Aged; Nervous System Diseases; Sleep Wake Disorders | 1998 |
[Long-lasting neuropsychiatric side-effects following mefloquine prophylaxis. A case after six weeks of initiating and lasting six months].
Topics: Adult; Antimalarials; Anxiety Disorders; Brain Diseases; Female; Headache; Humans; Mefloquine; Mental Disorders; Neurologic Examination; Time Factors; Vision Disorders | 1999 |
Neuropsychiatric problems in 2,500 long-term young travelers to the tropics.
Topics: Adolescent; Adult; Africa; Antimalarials; Asia, Southeastern; Cohort Studies; Female; Humans; Israel; Malaria; Male; Mefloquine; Mental Disorders; Middle Aged; Prevalence; Sex Factors; South America; Substance-Related Disorders; Surveys and Questionnaires; Travel; Tropical Climate | 2000 |
Health advice for travelers.
Topics: Antimalarials; Doxycycline; Humans; Malaria; Mefloquine; Mental Disorders; Travel | 2000 |
Cognitive and neuropsychiatric side effects of mefloquine.
Topics: Antimalarials; Cognition Disorders; Female; Humans; Malaria; Mefloquine; Mental Disorders; Middle Aged | 2001 |
Lariam's legacy.
Topics: Antimalarials; Consumer Product Safety; Doxycycline; Drug Costs; Humans; Malaria; Mefloquine; Mental Disorders; Naphthoquinones; Proguanil; United States; United States Food and Drug Administration | 2002 |
Malaria, mefloquine, madness, and mosquito nets.
Topics: Animals; Culicidae; Humans; Insect Bites and Stings; Malaria; Mefloquine; Mental Disorders | 1991 |
Neuropsychiatric side effects after the use of mefloquine.
Topics: Adult; Africa; Anxiety Disorders; Female; Germany; Humans; Male; Mefloquine; Mental Disorders; Psychoses, Substance-Induced; Seizures; Sleep Wake Disorders; Travel | 1991 |